Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.23 USD | +3.94% | +11.17% | -33.87% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
MarketScreener Editorial Features
Wall Street starts a new chapter | June 01, 2022 at 09:38 am EDT | |
MarketScreener's World Press Review : February 18, 2022 | February 18, 2022 at 12:13 pm EST |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- MarketScreener Editorial Features